Literature DB >> 12322927

Treating with spectacle lenses: a novel idea!?

Eli Peli1.   

Abstract

A design approach to low-vision device development-vision multiplexing-was introduced recently. This approach has been applied successfully to the design of novel electronic and optical low-vision aids. This paper discusses the application of the vision-multiplexing concept to spectacle lens design to address issues of low vision and to resolve problems of color discrimination and glare in driving. Because spectacles are considered a fashion accessory as much as they are a vision aid, cosmetic considerations are critical to the design of such aids. Spectacle-borne devices that are not concealed or attractive are unlikely to be used widely. Efforts to combine the functionality of vision multiplexing with improved appearance are illustrated.

Entities:  

Mesh:

Year:  2002        PMID: 12322927     DOI: 10.1097/00006324-200209000-00008

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  5 in total

1.  Extended wearing trial of Trifield lens device for 'tunnel vision'.

Authors:  Russell L Woods; Robert G Giorgi; Eliot L Berson; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2010-05       Impact factor: 3.117

2.  Impact of high power and angle of incidence on prism corrections for visual field loss.

Authors:  Jae-Hyun Jung; Eli Peli
Journal:  Opt Eng       Date:  2014-01-17

3.  Design considerations for the enhancement of human color vision by breaking binocular redundancy.

Authors:  Bradley S Gundlach; Michel Frising; Alireza Shahsafi; Gregory Vershbow; Chenghao Wan; Jad Salman; Bas Rokers; Laurent Lessard; Mikhail A Kats
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

4.  Testing Vision Is Not Testing For Vision.

Authors:  Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2020-12-18       Impact factor: 3.283

5.  Tunnel Vision Prismatic Field Expansion: Challenges and Requirements.

Authors:  Henry Apfelbaum; Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2015-12-31       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.